Tuberous Sclerosis Complex Market Analysis, Epidemiology and Market Forecast to 2030
Tuberous Sclerosis Complex (TSC) is a genetic disorder characterized by the growth of numerous non-cancerous (benign) tumors in many parts of the body. These tumors can occur in the skin, brain, kidneys, and other organs, in some cases leading to significant health problems. It was firstly described in the 1880s by French neurologist Désiré-Magloire Bourneville.
Key Highlight of Tuberous Sclerosis Complex Market As per National Institute Of Neurological Disorders and Stroke, Tuberous Sclerosis Complex affects as many as 25,000 to 40,000 individuals in the United States and about 1 to 2 million individuals worldwide, with an estimated prevalence of one in 6,000 newborns. As per Tuberous Sclerosis Alliance, at least two children born each day have Tuberous Sclerosis Complex. According to the National Organization of Rare Disorders, the prevalence in Europe is estimated to be approximately 1 in 25,000 to 1 in 11,300. As per the Graffigna et.al.2013, Tuberous Sclerosis Complex affects approximately 5000 individuals in Italy.
For more details visit: https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
